Literature DB >> 26432918

Illumination from light-emitting diodes (LEDs) disrupts pathological cytokines expression and activates relevant signal pathways in primary human retinal pigment epithelial cells.

Ye Shen1, Chen Xie2, Yangshun Gu1, Xiuyi Li1, Jianping Tong3.   

Abstract

Age-related macular degeneration (AMD) is the leading cause of blindness in the aged people. The latest systemic review of epidemiological investigations revealed that excessive light exposure increases the risk of AMD. With the drastically increasing use of high-energy light-emitting diodes (LEDs) light in our domestic environment nowadays, it is supposed to pose a potential oxidative threat to ocular health. Retinal pigment epithelium (RPE) is the major ocular source of pathological cytokines, which regulate local inflammation and angiogenesis. We hypothesized that high-energy LED light might disrupt the pathological cytokine expression of retinal pigment epithelium (RPE), contributing to the pathogenesis of AMD. Primary human RPE cells were isolated from eyecups of normal eye donors and seeded into plate wells for growing to confluence. Two widely used multichromatic white light-emitting diodes (LEDs) with correlated color temperatures (CCTs) of 2954 and 7378 K were used in this experiment. The confluent primary RPE cells were under white LEDs light exposure until 24 h. VEGF-A, IL-6, IL-8 and MCP-1 proteins and mRNAs were measured using an ELISA kit and RT-PCR, respectively. Activation of mitogen-activated protein kinases (MAPKs), Akt, Janus kinase (JAK)2 and Nuclear factor (NF)-κB signal pathways after LEDs illumination were evaluated by western blotting analysis. The level of reactive oxygen species (ROS) using chloromethyl- 2',7'-dichlorodihydrofluorescein diacetate. Inhibitors of relevant signal pathways and anti-oxidants were added to the primary RPE cells before LEDs illumination to evaluate their biological functions. We found that 7378 K light, but not 2954 K upregulated the VEGF-A, IL-6, IL-8 and downregulated MCP-1 proteins and mRNAs levels in a time-dependent manner. In parallel, initial activation of MAPKs and NF-κB signal pathways were also observed after 7378 K light exposure. Mechanistically, antioxidants for eliminating reactive oxygen species (ROS) and targeted inhibitors of MAPKs and NF-κB significantly blocked 7378 K light-induced changes of specific cytokines, respectively. Our findings suggest that 7378 K light, not 2954 K induced upregulation of VEGF-A, IL-6, IL-8 and downregulation of MCP-1 via ROS accumulation, activating MAPKs and NF-κB signal pathways.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AMD; Light-emitting diodes; MAPK; NF-κB; Oxidative stress; Pathological cytokine; RPE cells

Mesh:

Substances:

Year:  2015        PMID: 26432918     DOI: 10.1016/j.exer.2015.09.016

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  4 in total

1.  Bevacizumab induces oxidative cytotoxicity and apoptosis via TRPM2 channel activation in retinal pigment epithelial cells: Protective role of glutathione.

Authors:  Dilek Özkaya; Mustafa Nazıroğlu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-02-05       Impact factor: 3.117

2.  Effect of light-emitting diodes with different color rendering indexes on the ocular tissues of rat.

Authors:  Wen-Yi Chen; Kun-Hong Xiao; Rong Lin; Ze-Ren Qiu; Ya-Min Chen; Ze-Qun Lin; Xiu-Bin Ke; Yan Huang
Journal:  Int J Ophthalmol       Date:  2022-07-18       Impact factor: 1.645

3.  Interleukin-2 induces extracellular matrix synthesis and TGF-β2 expression in retinal pigment epithelial cells.

Authors:  Ruihua Jing; Tiantian Qi; Chan Wen; Jiaqi Yue; Guangyan Wang; Cheng Pei; Bo Ma
Journal:  Dev Growth Differ       Date:  2019-10-13       Impact factor: 2.053

4.  The inflammatory immune system after wake up in healthy male individuals: A highly standardized and controlled study.

Authors:  Katja Petrowski; Bjarne Schmalbach; Mona Linhardt; Liza Mekschrat; Nicolas Rohleder
Journal:  Brain Behav Immun Health       Date:  2022-08-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.